Extensive Pyoderma Gangrenosum Associated With Granulomatosis With Polyangiitis With Both Responsive to Rituximab.

Detalles Bibliográficos
Publicado en:JRC: Journal of Clinical Rheumatology Vol. 22; no. 7; pp. 393 - 396
Autores principales: Murthy, Rajini K, Jackson, Jeremy, Chatham, Walter Winn, Sami, Naveed
Formato: case study Journal Article
Publicado: Lippincott Williams & Wilkins Oct2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120354237&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 120354237
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10761608
        N16
      jtl: JRC: Journal of Clinical Rheumatology
      issn: 10761608
      maglogo: N
    pubinfo:
      dt: Oct2016
      vid: 22
      iid: 7
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        120354237
        120354237
        NLM27660945
        118516980
        10.1097/RHU.0000000000000447
        NLM27660945
        120354237
      ppf: 393
      ppct: 3
      formats:
      tig:
        atl: Extensive Pyoderma Gangrenosum Associated With Granulomatosis With Polyangiitis With Both Responsive to Rituximab.
      aug:
        au:
          Murthy, Rajini K
          Jackson, Jeremy
          Chatham, Walter Winn
          Sami, Naveed
        affil: Department of Dermatology Emory University Atlanta, GA Department of Dermatology University of Mississippi Oxford, MS Division of Clinical Immunology and Rheumatology University of Alabama at Birmingham Birmingham, AL Department of Dermatology University of Alabama at Birmingham Birmingham, AL
      sug:
        subj:
          Granulomatosis with Polyangiitis Drug Therapy
          Pyoderma Gangrenosum Drug Therapy
          Granulomatosis with Polyangiitis Complications
          Antirheumatic Agents Therapeutic Use
          Male
          Pyoderma Gangrenosum Complications
          Middle Age
          Middle Aged: 45-64 years
          Male
      pubtype: Academic Journal
      doctype:
        case study
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N